NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst
Go back to NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 54.00 -1.28 (2.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.28 | 52 Week High | $77.12 | |||
| Open | $55.20 | 52 Week Low | $49.03 | |||
| Day High | $55.33 | P/E | 35.06 | |||
| Day Low | $53.44 | EPS | $1.54 | |||
| Volume | 31,700,384 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 123.76 -1.69 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.45 | 52 Week High | $108.63 | |||
| Open | $125.85 | 52 Week Low | $71.39 | |||
| Day High | $126.39 | P/E | 68.38 | |||
| Day Low | $122.43 | EPS | $1.81 | |||
| Volume | 14,348,344 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 451.63 -7.36 (1.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $458.99 | 52 Week High | $134.71 | |||
| Open | $462.17 | 52 Week Low | $73.31 | |||
| Day High | $464.98 | P/E | N/A | |||
| Day Low | $450.39 | EPS | $-1.98 | |||
| Volume | 2,993,024 | |||||
